WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Scott MooreDirector2026-06-1121,700$11.53
$250.24kBuy
Richard A. Md MillerPresident and CEO2026-05-181,932$12.01
$23.20kBuy
Richard A. Md MillerPresident and CEO2026-05-185,000$12.05
$60.25kBuy
Peter A. ThompsonDirector2026-01-2815,000$12.50
$187.50kBuy
Peter A. ThompsonDirector2026-01-2815,000$3.61
$54.15kBuy
Peter A. ThompsonDirector2026-01-2815,000$2.00
$30.00kBuy
Peter A. ThompsonDirector2026-01-2815,000$3.27
$49.05kBuy
Peter A. ThompsonDirector2026-01-2815,000$2.74
$41.10kBuy
Peter A. ThompsonDirector2026-01-2815,000$2.60
$39.00kBuy
Peter A. ThompsonDirector2026-01-2815,000$0.99
$14.85kBuy

1 of 2

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter A. Thompson10.48%8,819,091$115.62MInsider
Orbimed Advisors LLC8.52%7,165,006$93.93MInsider
Ecor1 Capital LLC6.14%5,162,154$67.68MInsider
Terry P. Gould4.04%3,402,422$44.61MInsider
Adams Street Partners LLC4.04%3,402,422$44.61MInsider
Richard A. Md Miller2.77%2,331,742$30.57MInsider
Holdings A. Novo1.65%1,389,498$18.22MInsider
Joseph J. Buggy0.42%351,186$4.60MInsider
Leiv Lea0.34%282,444$3.70MInsider
William Benton Jones0.21%173,130$2.27MInsider

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS0.08%38.91%Net Buying
ALMS0.09%28.51%Net BuyingNet Buying
ATTO0.00%62.28%Net BuyingNet Buying
SVRA0.09%99.91%Net SellingNet Buying
JBIO0.11%30.08%Net Buying
View Top Biotech Stocks

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 0.08% institutional shareholders, 38.91% Corvus Pharmaceuticals insiders, and 61.00% retail investors. Peter A. Thompson is the largest individual Corvus Pharmaceuticals shareholder, owning 8.82M shares representing 10.48% of the company. Peter A. Thompson's Corvus Pharmaceuticals shares are currently valued at $114.21M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.